Applied Biosciences Corp. (APPB)
Applied Biosciences Corp. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Beverly Hills, CA, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $2,200. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -865.3%. Its beta of -2.34 implies it has historically moved less than the broad market.
Applied Biosciences Corp. is dedicated to the creation and market launch of synthetic cannabinoid biopharmaceutical treatments. These advanced therapeutics are specifically designed to interact with the body's endocannabinoid system, aiming to address a wide array of diseases across diverse medical specialties. Furthermore, the company offers over-the-counter, THC-free CBD products directly to consumers, which are intended to support general health and well-being. It also provides specialized testing and analytical services to its customers. The firm was founded in 2014 and operates from its base in Beverly Hills, California.
Applied Biosciences Corp. is most often compared with the following Healthcare names: